Adam Maeder
Stock Analyst at Piper Sandler
(4.08)
# 418
Out of 4,827 analysts
85
Total ratings
56.14%
Success rate
10.73%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $9.90 | +41.41% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $246.77 | +0.50% | 3 | Apr 24, 2025 | |
| EW Edwards Lifesciences | Upgrades: Overweight | $73 → $80 | $75.90 | +5.40% | 14 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $545.35 | +5.44% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $134.98 | +7.43% | 3 | Apr 17, 2025 | |
| RXST RxSight | Initiates: Neutral | $18 | $13.73 | +31.10% | 1 | Apr 15, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $8.81 | -3.50% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $153.25 | +52.04% | 14 | Feb 10, 2025 | |
| NSPR InspireMD | Reiterates: Overweight | $4.5 | $2.56 | +75.78% | 3 | Sep 17, 2024 | |
| M Macy's | Maintains: Hold | $20 → $21 | $11.90 | +76.47% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $4.76 | +68.07% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $6.26 | +219.74% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.17 | +130.41% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.16 | +733.33% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $44.41 | +122.92% | 3 | May 5, 2022 |
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $9.90
Upside: +41.41%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $246.77
Upside: +0.50%
Edwards Lifesciences
Apr 24, 2025
Upgrades: Overweight
Price Target: $73 → $80
Current: $75.90
Upside: +5.40%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $545.35
Upside: +5.44%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $134.98
Upside: +7.43%
RxSight
Apr 15, 2025
Initiates: Neutral
Price Target: $18
Current: $13.73
Upside: +31.10%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $8.81
Upside: -3.50%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $153.25
Upside: +52.04%
InspireMD
Sep 17, 2024
Reiterates: Overweight
Price Target: $4.5
Current: $2.56
Upside: +75.78%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $11.90
Upside: +76.47%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $4.76
Upside: +68.07%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $6.26
Upside: +219.74%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.17
Upside: +130.41%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.16
Upside: +733.33%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $44.41
Upside: +122.92%